How the LDT Final Rule’s Exemptions Apply to Oncology Labs
Regulatory expert explores whether any exclusions might benefit cancer laboratories trying to navigate upcoming compliance deadlines
Regulatory expert explores whether any exclusions might benefit cancer laboratories trying to navigate upcoming compliance deadlines
This template helps lab leaders implement a written policy limiting and establishing procedures governing use of PHI for marketing.
This template helps labs create a fact sheet that highlights the key HIPAA-related do’s and don’ts for marketing staff.
Though COVID-19 testing declines continue to negatively affect lab industry profits, the latest figures suggest the worst may be over.
Recent cases involve charges and judgments related to COVID-19 add-on tests, genetic testing fraud, and kickbacks.
While overpayments may not be your fault, they expose your lab to the risk of liability under the Affordable Care Act.
What do lab professionals need to do to ensure sufficient documentation for billing clinical laboratory and pathology services?
Performing your own audit to verify compliance and identify problems is one key to achieving a successful FDA audit.
In last month’s key cases, Illumina and Guardant seek to dismiss lawsuit related to trade secrets and breach of contract.
A strategic partnership with Google enables more accurate whole genome sequencing with machine learning.
More multiplex COVID-19 combination tests emerge from premarket authorization pipeline.